GlaxoSmithKline shingles vaccine hits goal in major study
December 18, 2014 at 07:42 AM EST
LONDON, Dec 18 (Reuters) - An experimental vaccine against shingles from GlaxoSmithKline met its goal in a late-stage study, in a boost for the company's vaccine unit, which is expanding part of its overall healthcare business.